Back to Journals » OncoTargets and Therapy » Volume 11

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

Total article views   Abstract views HTML views PDF downloads Totals
6,072 Dovepress* 3,799 1,363+ 1,234 5,162
PubMed Central* 0 910 241 910
Totals 3,799 2,273 1,475 6,072
*Since 22 December 2017
+Since July 2016

View citations on PubMed Central and Google Scholar